Clinical Trial Update: Pregnenolone in the Management of Schizophrenia Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating pregnenolone for the management of schizophrenia has completed, reporting early safety and tolerability data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Pregnenolone (pregnenolone)

Snippet

Sponsor: Sha'ar Menashe Mental Health Center | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED